18:06 EST Milestone Pharmaceuticals (MIST) trading halted, news pending
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MIST:
- Milestone Pharmaceuticals: Buy Rating Reaffirmed Amid Imminent PDUFA Date and Misunderstood CRL Implications
- Milestone Pharmaceuticals Reports Q3 2025 Financial Results
- Milestone Pharmaceuticals Prepares for CARDAMYST Launch Amid Financial Growth
- Milestone Pharmaceuticals: Positioned for Success with Cardamyst’s Potential Approval and Launch
- Milestone Pharmaceuticals reports Q3 EPS (12c), consensus (17c)